Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics
Award Notice Posted
- Solicitation number
- 75F40124R00002-Acumen
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Awarded
- to Acumen LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75F40124D00041 Federal IDV award
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) Office of Acquisition and Grant Services has awarded a multiple-award Indefinite Delivery/Indefinite Quantity (ID/IQ) contract to ACUMEN LLC for the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics. The contract has a ceiling value of $75,000,000 for each awarded contract to provide health care data sources for surveillance of biologics.
Notice text
Multiple Award Indefinite Delivery / Indefinite Quantity (ID/IQ) contract for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3).
$75,000,000.00 IDIQ ceiling for each contract.
Awarded contract 75F40124D00041 to ACUMEN LLC for 75000000.00 on 2024-09-27.
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity